Diplomacy is now a neglected global issue; this text seeks to not only identify current problems diplomacy is facing but also identify some practical options for reform and innovation.
Of the nearly 500 First Opinion essays published by STAt in 2022, written by more than 700 authors from the biopharmaceutical industry, health care, academia, government, and private life in the United States and beyond, Menchik’s recollection of taking part in the Moderna COVID-19 vaccine trial was the site’s most viewed.
Storella and Homes urge the Biden administration to challenge China to reinforce links between governance and health in Africa and conclude, “The Biden administration is wisely leaning into areas of shared values, priorities, and aspirations with Zambia’s Hichilema administration…to amplify the impact of investments to improve the lives of people in African countries.”
SFP publishes public health, social science, and biomedical research with a primary focus on low- and middle-income countries. For almost sixty years, peer-reviewed research in the journal has played a pivotal role in shaping the field and building the evidence base for improving policy and practice.
“Tensions between the world’s two largest powers will persist. But collaborative health projects in Africa could build bridges, advance shared goals and strengthen African countries’ health systems.”
Professor Karra presented findings from two field experiments he has conducted over several years in Malawi to measure the impacts of family planning on contraceptive use, fertility health, and longer-term well-being.
Pardee School professors Kevin Gallagher and Mark Storella were joined by Nahid Bhadelia, founding director of BU’s CEID and Associate Director at BU’s NEIDL, to discuss the efficacy of vaccine diplomacy throughout the COVID-19 pandemic.
In an interview with Tavis Smiley, Professor Menchik discusses why he resigned from the Moderna COVID-19 vaccine trials and his efforts to mobilize fellow trail participants to pressure Moderna to share the protection provided by their vaccine globally.
“We have to treat this pandemic as a global crisis, as a global public health emergency. And that means that Moderna needs to think about not just selling vaccines to rich countries…but seriously scaling up the technology so that the world can be vaccinated and boosted.”
“While the process of science and the products it yields are noble, science for outrageous profit that costs people their lives is not noble. That is why I can no longer in good conscience be part of Moderna’s trials.”
In reflecting on 2021, Pardee School faculty offer their thoughts on the lessons that can be gleaned from this past year. Chief among the responses: multilateralism and global democracy are in decline.
Climate change is no longer just about carbon mitigation but also an issue of systemic structural inequalities, sustainable development, and global inaction.
Two of Professor Karra’s papers were featured in JMIR Research Protocols and the Journal of the Royal Statistical Society.
Incoming Professor Mark C. Storella outlines the need for U.S. diplomatic leadership on global health in the age of COVID-19.
Live-streamed seminar, hosted by the Pardee Center, looks at the global responses to and implications of the COVID-19 pandemic (video recording available).